Overview

Oral Dexmedetomidine in Pediatric MRI

Status:
Not yet recruiting

Trial end date:
2025-12-01

Target enrollment:

Participant gender:

Summary

The objective of this preliminary study is to assess the utility of oral dexmedetomidine as the sole sedative agent in pediatric population undergoing MRI

Phase:

Phase 1

Details

Lead Sponsor:

Children's Mercy Hospital Kansas City

Treatments:

Anesthetics
Anesthetics, General
Dexmedetomidine